Short-term benefit from oral vancomycin treatment of regressive-onset autism. - Wikidata - wikimedia - TriplyDB

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

http://www.wikidata.org/entity/Q33911971

about

Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances Complementary and alternative medicine treatments for children with autism spectrum disorders Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis Stem cell therapy for autism Aminoglycoside antibiotics and autism: a speculative hypothesis Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?Gut microbiota in autism and mood disorders Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation Gut microbial communities modulating brain development and function The intestinal microbiome in early life: health and disease Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood Can probiotics benefit children with autism spectrum disorders?Microbial endocrinology: the interplay between the microbiota and the endocrine system Human Microbiome: When a Friend Becomes an Enemy The role of microbiome in central nervous system disorders In vitro fermentation of B-GOS: impact on faecal bacterial populations and metabolic activity in autistic and non-autistic children Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.Gut microbioma population: an indicator really sensible to any change in age, diet, metabolic syndrome, and life-style.Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.Approaches to studying and manipulating the enteric microbiome to improve autism symptoms Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.The neurotoxic effects of ampicillin-associated gut bacterial imbalances compared to those of orally administered propionic acid in the etiology of persistent autistic features in rat pups: effects of various dietary regimens.May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry.Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder.Characteristics of the gastrointestinal microbiome in children with autism spectrum disorder: a systematic review.Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders.Brain-gut axis in the pathogenesis of Helicobacter pylori infection The Gut Microbiota and Autism Spectrum Disorders.'Gut health': a new objective in medicine?Autistic enterocolitis: fact or fiction?Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia.Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism.The effects of gut microbiota on CNS function in humans.

P2860

Q21132990-15EC4987-47E4-4041-BBB1-5DEA159C382E Q21560928-4A27E023-EAAA-4A59-BA83-05B3524CF2BD Q22252305-E2D903F0-AC7D-46A3-A304-FA20304E2E32 Q24630557-59D9CCF9-C8DD-4AA6-BE8D-B586118E5489 Q24676771-307BEB70-C912-4D44-90B1-B34AE831203A Q24793618-013F0BCB-C717-45F5-9E21-3C1049C48B09 Q26744037-1B9007AE-2AE6-42E4-A8B5-E423AE0D4A36 Q26749210-C919B8FD-77CB-407D-BBE7-8A55ADFA80A5 Q26766586-5D8E4A2D-A5CE-4DB1-B600-274B3817F47B Q26772308-5D68ADF7-26B6-4C4E-8F33-20EFA4A86BC4 Q26824638-6A1AB7A0-0B44-4A49-90A8-7DB97CD3B591 Q26827364-AA6340A9-88A4-486A-8138-7C4877276EE9 Q26996343-91D07E44-9A0A-4808-86A1-FA8C70B8DE6E Q27024805-6F3506FD-963E-4F98-A366-F9D1B38E25D6 Q27496651-55367954-3737-4BC5-A211-1B8FDB62C02C Q27928004-D716ABF2-3A39-484B-83DC-EB3ACCD0E5EC Q28075770-22619750-8267-4F0D-A210-05B55B247AB4 Q28076833-6CC766A1-BBA4-413B-B728-262B95C8255E Q28083570-1830852A-3A39-41A0-B89A-D81BBAE2A78C Q28085629-01C7019B-5AC5-499E-A9B0-0FF066D5AC2E Q28304749-26034C23-1F89-4312-99F4-9374AFE1DE38 Q28587344-AD47F7AB-1DAA-4DB4-B848-7CA2B9902ECB Q30363954-20B2C8A4-7523-48E7-887C-0A104BD231F4 Q30364423-C1767F36-CECA-4FFD-B749-7D7AF6C0E7B5 Q30404383-43B21108-51D9-4AFC-8B5E-6D83A319FF3C Q30410992-ACDB0F2D-CA66-478A-B48B-A1018AA30365 Q30410996-8304ACA9-41DF-4940-A555-3FD423758FF8 Q30414647-E242C6FA-CC3C-47C8-A6C7-76C6622AF7AE Q30489570-8AF9DD62-68F7-46B2-8E18-D0568F99075E Q30534798-22B0714D-6624-4ED1-BB62-0D86D0499709 Q30843140-009939B0-3A21-40C9-BAA4-B09A376F1F80 Q31171301-DF6CD201-7D46-4154-A1B5-0FF4F7E749D9 Q33427134-AFF88A6B-6799-44AB-846A-86147FE29723 Q33594833-9162CCC3-FF78-43E6-B0A0-4F5BC3109896 Q33613009-829B67E6-C73E-4CCF-88EE-1005E1E5FCD8 Q33845395-7CD73D07-0F64-47EE-A0B9-7753EA6ACD37 Q34016095-8D65DF85-B007-4DC4-A649-583CD97CC4A8 Q34112421-BA780B33-18C5-42FC-83EC-01A9203A9A7E Q34126446-A90CE07D-F654-4869-977C-F9E6480C4E5D Q34129414-3EAEBFE6-D833-4C6E-8FD9-731E7613DFCE

P2860

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

http://www.wikidata.org/entity/Q33911971

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@ast

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@en

type

label

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@ast

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@en

prefLabel

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@ast

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@en

P1433

Q33911971-B0FB7FBE-6AF4-417A-B15D-8F3B8B7EA7A8

P1476

Q33911971-A30178F0-8B8D-4D0C-8D65-F4591A95F6CC

P2093

Q33911971-1AFC915C-22DA-40E1-BDF5-D3231BA3E356

Q33911971-2B4AE841-92A6-43C8-8A5D-59CA32E1D9D0

Q33911971-945605A7-04C8-44F3-B081-0105847E7512

Q33911971-97F707EB-C819-4F11-8CDE-21509740F1A2

Q33911971-9E6D9B01-A89D-4B9F-B722-BDA1159D222C

Q33911971-B1BB472B-C4CF-4771-8957-4274726C8471

Q33911971-B92085CF-D620-4BEC-AF5B-B4F01C267823

Q33911971-F275B5DC-7785-4746-9B93-536500F39AFA

P2860

Q33911971-214D070A-32CB-4858-9B7C-12E4ED96F6BA

Q33911971-29F1A0F3-C908-467E-8F60-84C0DF4A592B

Q33911971-352C7E2A-D4E7-4E38-8582-79093B1D4E1C

Q33911971-3ADB0BC4-3240-4A4A-BFA4-0B2AEB3CD6F6

Q33911971-4490BC28-2BBF-4AE2-9699-D29E754D7972

Q33911971-74205D01-8FB8-4558-BAAA-3B65BBD60D0A

Q33911971-77141302-C51D-4EE2-AACE-882C6765BECD

Q33911971-9349B454-2EC0-4313-9028-2CCA6DBCAD9D

Q33911971-95788ED7-BA0D-40AC-875C-5800EBFF20CB

Q33911971-973F2C01-0823-4E21-8B27-1D2D6457CF4D

P304

Q33911971-C0543EB0-4B43-4C65-927A-46E86197AF39

P31

Q33911971-9727BCAC-DD7F-4952-B9C2-02E119DDA8F6

P356

Q33911971-C47C79D9-5CFB-4805-894F-D21A330A331D

P433

Q33911971-45ED6BB2-A3E9-4479-9714-7EF4E82FE631

P478

Q33911971-3F215743-B8AE-47AC-8241-A3A55D736642

P577

Q33911971-8CC7E507-0A4D-4FAB-9E59-6DA81D7A6E01

P5875

Q33911971-254D2483-C1A5-4751-A165-0C4FE1FA493A

P698

Q33911971-9870655A-98C1-4FFC-BDED-CFEEA404D722

P921

Q33911971-1997E7EE-F3E1-4C43-9A9E-43FB42A1D8EB

P356

088307380001500701

P1433

Journal of Child Neurology

P1476

Short-term benefit from oral vancomycin treatment of regressive-onset autism.

@en

P2093

A P Maxwell

http://www.w3.org/2001/XMLSchema#string

C P Buchanan

http://www.w3.org/2001/XMLSchema#string

E R Bolte

http://www.w3.org/2001/XMLSchema#string

H M Wexler

http://www.w3.org/2001/XMLSchema#string

M L Väisänen

http://www.w3.org/2001/XMLSchema#string

M N Nelson

http://www.w3.org/2001/XMLSchema#string

R H Sandler

http://www.w3.org/2001/XMLSchema#string

S M Finegold

http://www.w3.org/2001/XMLSchema#string

P2860

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

Mechanism of action of tetanus and botulinum neurotoxins

Circulating autoantibodies to neuronal and glial filament proteins in autism.

Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.

The faecal flora of children in the United Kingdom.

Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Reassessment of verbal and visual analog ratings in analgesic studies.

Effect of broad-spectrum parenteral antibiotics on "colonization resistance" of intestinal microflora of humans.

State of the science in autism: report to the National Institutes Health.

Botulism in the United States: a clinical and epidemiologic review.

P304

429-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/088307380001500701

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12397487

http://www.w3.org/2001/XMLSchema#string

P698

10921511

http://www.w3.org/2001/XMLSchema#string

P921